AZD8683 multiple dose study in healthy volunteers and Chronic obstructive pulmonary disease (COPD) patients

Study identifier:D1883C00002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

A Phase I, Single Centre, Double-Blind, Randomised, Placebo- controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Inhaled Doses of AZD8683 in Healthy Volunteers and COPD patients

Medical condition

COPD

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD8683, Placebo

Sex

All

Actual Enrollment

30

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Jun 2012
Primary Completion Date: 01 Nov 2012
Study Completion Date: 01 Nov 2012

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Dec 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria